These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 11328414

  • 1. P53, bcl-2, and bax: their relationship and effect on prognosis in early stage epithelial ovarian carcinoma.
    Skirnisdóttir I, Sorbe B, Seidal T.
    Int J Gynecol Cancer; 2001; 11(2):147-58. PubMed ID: 11328414
    [Abstract] [Full Text] [Related]

  • 2. The prognostic importance of p53, bcl-2, and bax in early stage epithelial ovarian carcinoma treated with adjuvant chemotherapy.
    Skirnisdóttir I, Seidal T, Gerdin E, Sorbe B.
    Int J Gynecol Cancer; 2002; 12(3):265-76. PubMed ID: 12060448
    [Abstract] [Full Text] [Related]

  • 3. The apoptosis regulators p53, bax and PUMA: Relationship and impact on outcome in early stage (FIGO I-II) ovarian carcinoma after post-surgical taxane-based treatment.
    Skírnisdóttir I, Seidal T.
    Oncol Rep; 2012 Mar; 27(3):741-7. PubMed ID: 22159712
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer.
    Apolinario RM, van der Valk P, de Jong JS, Deville W, van Ark-Otte J, Dingemans AM, van Mourik JC, Postmus PE, Pinedo HM, Giaccone G.
    J Clin Oncol; 1997 Jun; 15(6):2456-66. PubMed ID: 9196162
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen.
    Kupryjańczyk J, Szymańska T, Madry R, Timorek A, Stelmachów J, Karpińska G, Rembiszewska A, Ziółkowska I, Kraszewska E, Debniak J, Emerich J, Ułańska M, Płuzańska A, Jedryka M, Goluda M, Chudecka-Głaz A, Rzepka-Górska I, Klimek M, Urbański K, Breborowicz J, Zieliński J, Markowska J.
    Br J Cancer; 2003 Mar 24; 88(6):848-54. PubMed ID: 12644821
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The growth factor receptors HER-2/neu and EGFR, their relationship, and their effects on the prognosis in early stage (FIGO I-II) epithelial ovarian carcinoma.
    Skirnisdóttir I, Sorbe B, Seidal T.
    Int J Gynecol Cancer; 2001 Mar 24; 11(2):119-29. PubMed ID: 11328410
    [Abstract] [Full Text] [Related]

  • 11. Bax, Bcl-2, and p53 expression in endometrial cancer.
    Sakuragi N, Salah-eldin AE, Watari H, Itoh T, Inoue S, Moriuchi T, Fujimoto S.
    Gynecol Oncol; 2002 Sep 24; 86(3):288-96. PubMed ID: 12217750
    [Abstract] [Full Text] [Related]

  • 12. p53 and related proteins in epithelial ovarian cancer.
    Sengupta PS, McGown AT, Bajaj V, Blackhall F, Swindell R, Bromley M, Shanks JH, Ward T, Buckley CH, Reynolds K, Slade RJ, Jayson GC.
    Eur J Cancer; 2000 Dec 24; 36(18):2317-28. PubMed ID: 11094305
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prognostic significance of Bax, Bcl-2, and p53 expressions in cervical squamous cell carcinoma treated by radiotherapy.
    Wootipoom V, Lekhyananda N, Phungrassami T, Boonyaphiphat P, Thongsuksai P.
    Gynecol Oncol; 2004 Sep 24; 94(3):636-42. PubMed ID: 15350352
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. THE PROGNOSTIC SIGNIFICANCE OF P53, BCL2 AND MIB1 EXPRESSIONS RELATED WITH OTHER CLINICOPATHOLOGICAL VARIABLES IN SEROUS OVARIAN CARCINOMAS. A CLINICOPATHOLOGICAL STUDY IN PERITONEAL FLUIDS.
    Kalogeraki A, Tamiolakis D, Matalliotaki C, Karvela-Kalogeraki I, Karvelas-Kalogerakis M, Segredakis J, Sinatkas V, Matalliotakis I.
    Rev Med Chir Soc Med Nat Iasi; 2015 Sep 24; 119(2):454-60. PubMed ID: 26204652
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Expression of apoptosis-related proteins is an independent determinant of patient prognosis in advanced ovarian cancer.
    Baekelandt M, Holm R, Nesland JM, Tropé CG, Kristensen GB.
    J Clin Oncol; 2000 Nov 15; 18(22):3775-81. PubMed ID: 11078490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.